Compass Therapeutics, Inc.

CMPX · NasdaqCM

Add to watchlist

$0.75−0.32%(−0.00)

Yahoo Finance · delay unknown · USD · 2 min old

Price history

Oct 28, 2025 · 4.10 USDOct 28, 2026 · 0.75 USD

Yahoo Finance · delay unknown · USD · 5 h old

Key figures

Previous close: 0.75
Day range: 0.73 – 0.77
Volume: 810.4K
Market cap: —

Information, not investment advice.

News about Compass Therapeutics, Inc.

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Compass Therapeutics' tovecimig treatment met primary and key secondary endpoints in a Phase 2/3 trial, showing improved disease control.· summarised by Stockedin

Yahoo4 days agoRead at the source

CMPX

Finnhub · delay unknown · 4 days old

Headline and publisher summary only; full articles stay with the source.